BD PROJECTS

• Product for Licensing

  DrugTimes BD Project | A Anti-C3 Nanobody Indicated for Geographic Atrophy

  2025年7月28日
• Immunology

  Seeking Partners for a Bispecific Antibody Targeting IL4Rα/IL13 and IL31 for Atopic Dermatitis | DrugTimes BD Project

  2025年7月24日
• Request for Product

  Seeking Innovative Ophthalmology Drug Projects, Considering Small Molecules, Monoclonal/Polyclonal Antibodies, Nucleic Acid Drugs, Molecular Glues, Gene Therapies…

  2025年7月21日
• Request for Product

  Several Pharma Giants Vie for Next-Gen Obesity and Diabetes Therapies

  2025年7月18日
• Request for Product

  Global market opportunity! Buyers in urgent need of CNS-related products/platforms.

  2025年7月17日
• CNS/Pain

  【IND enabling】TYK2/JAK1 Dual Inhibitor Breaks New Ground in CNS Drug Development【Product for Licensing】

  2025年7月15日
• Product for Licensing

  【IND enabling】Once daily oral brain-penetrant dual JAK1/TYK2 inhibitor with better efficacy and safety【Product for Licensing】

  2025年6月17日
• Oncology

  【pre-PCC】A Potential Best-in-Class CDK2 Inhibitor with Better Selectivity, Better Efficacy and Superior PK【Product for Licensing】

  2025年6月17日
• Product for Licensing

  【Phase I】First-in-class Phase I Dual-target Oral Molecular Glue for Hematologic Malignancies with Broad-spectrum Activity and Better Safety Profile 【Product for Licensing】

  2025年6月17日
• Product for Licensing

  【IND enabling】Once daily oral brain-penetrant dual JAK1/TYK2 inhibitor with better efficacy and safety

  2025年4月30日